Literature DB >> 31067484

Defining a Minimal Effective Serum Trough Concentration of Secukinumab in Psoriasis: A Step toward Personalized Therapy.

Rani Soenen1, Evelyn Meulewaeter1, Lynda Grine1, Nathalie Van den Berghe2, Els Brouwers2, Reinhart Speeckaert1, Sven Lanssens3, Linda Temmerman4, Jo Lambert1, Ann Gils5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31067484     DOI： 10.1016/j.jid.2019.04.012

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  5 in total

1.  Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?

Authors:  Tasnim Abdalla; Michelle A Lowes; Nirmal Kaur; Robert G Micheletti; A Hillary Steinhart; Afsaneh Alavi
Journal:  Am J Clin Dermatol       Date:  2021-03       Impact factor: 6.233

Review 2.  Achieving Mucosal Healing in Inflammatory Bowel Diseases: Which Drug Concentrations Need to Be Targeted?

Authors:  Nathalie Van den Berghe; Ann Gils; Debby Thomas
Journal:  Clin Pharmacol Ther       Date:  2019-09-20       Impact factor: 6.875

3.  The Effects of Modified Intermittent Fasting in Psoriasis (MANGO): Protocol for a Two-Arm Pilot Randomized Controlled Open Cross-over Study.

Authors:  Lynda Grine; Niels Hilhorst; Nathalie Michels; Souheila Abbeddou; Stefaan De Henauw; Jo Lambert
Journal:  JMIR Res Protoc       Date:  2022-02-23

4.  Therapeutic drug monitoring in dermatology: the way towards dose optimization of secukinumab in chronic plaque psoriasis.

Authors:  Rani Soenen; Zhigang Wang; Lynda Grine; Erwin Dreesen; Lisa Schots; Els Brouwers; Paul Declerck; Debby Thomas; Jo Lambert
Journal:  Clin Exp Dermatol       Date:  2022-04-25       Impact factor: 4.481

Review 5.  Impact of Pharmacokinetic and Pharmacodynamic Properties of Monoclonal Antibodies in the Management of Psoriasis.

Authors:  Karine Rodríguez-Fernández; Víctor Mangas-Sanjuán; Matilde Merino-Sanjuán; Antonio Martorell-Calatayud; Almudena Mateu-Puchades; Mónica Climente-Martí; Elena Gras-Colomer
Journal:  Pharmaceutics       Date:  2022-03-16       Impact factor: 6.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.